A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers

Clinical trial NCT01855048 · COMPLETED

Trial details

NCT number: NCT01855048
Sponsor: Intron Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus

Start date: 2013-08-06
Primary completion: 2014-02-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.